NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B
2009 NOV 16 ... Reverse Transcriptase Inhibitor, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Oncology, Pharmaceuticals, Regulatory Actions, Septic Shock, Tenofovir, Tenofovir ...
Subject: Gilead Sciences, Inc.
Price: $3.00
*
Gilead Sciences Announces Record Third Quarter 2009 Financial Results
2009 NOV 2 ... Reverse Transcriptase Inhibitor, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Oseltamivir, Oseltamivir Phosphate, Pandemics, Pharmaceutical Business, Pharmaceutical ...
Subject: Gilead Sciences, Inc.
Price: $3.00
*
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
2009 SEP 28 ... Reverse Transcriptase Inhibitor, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Quality of Care, Regulatory Actions, Tenofovir Disoproxil Fumarate, ...
Subject: HIV/AIDS
Price: $3.00
*
New findings in HIV/AIDS described by L. Bansi and co-researchers
2009 SEP 21 ... Kingdom, London, HIV/AIDS, Abacavir, Anti-HIV, Anti-Infectives, Antivirals, HAART, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Tenofovir, Therapy, Treatment, Viral Load, Virology. This article was ...
Subject: HIV/AIDS
Price: $3.00
*
New life sciences findings from University of Genova described
2009 SEP 21 ... Drugs, Treatment, Lamivudine, Immunology, Tenofovir, Anti-HIV, Antiviral, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Life Sciences
Price: $3.00
*
New patents research from T. Amin and colleagues discussed
2009 OCT 5 ... USA. Keywords: United States, Lewes, Anti-HIV, Antivirals, Business, Drugs, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Patents Actions, Pharmaceuticals, Tenofovir Disoproxil Fumarate, Therapy, Treatment. ...
Subject: Patents
Price: $3.00
*
New research on renal disease from B. Young and co-authors summarized
2009 SEP 14 ... Anti-HIV, Antivirals, HAART, HIV, Human Immunodeficiency Virus, Kidney, Nephrology, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Renal Disease, Renal Function, Tenofovir, Therapy, Treatment, Virology. ...
Subject: Renal Disease
Price: $3.00
*
Reports from J.L. Lennox and colleagues advance knowledge in HIV/AIDS
2009 OCT 5 ... Drug Resistance, Drugs, Efavirenz, Emtricitabine, HIV, Human Immunodeficiency Virus, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Raltegravir, Tenofovir, Therapy, Treatment, Virology. ...
Subject: HIV/AIDS
Price: $3.00
*
Reports from U.M. Parikh et al highlight recent research in virology
2009 NOV 16 ... Trials, Drugs, Emtricitabine, Enzymes, HIV, Human Immunodeficiency Virus, Immunology, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Pre-Trials Research, Proteins, Proteomics, Sexually Transmitted ...
Subject: Virology
Price: $3.00
*
Reports on HIV/AIDS findings from L. Calza and co-researchers provide new insights
2009 OCT 5 ... Reverse Transcriptase Inhibitor, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Protease Inhibitor, Protease Inhibitors, Ritonavir, Stavudine, ...
Subject: HIV/AIDS
Price: $3.00
*
Research from University of Liverpool reveals new findings on HIV/AIDS clinical trial
2009 OCT 12 ... Human Immunodeficiency Virus, Lamivudine, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Protease Inhibitor, Protease Inhibitors, Proteins, Proteomics, ...
Subject: HIV/AIDS Clinical Trial
Price: $3.00
*
Research on HIV/AIDS described by scientists at GlaxoSmithKline
2009 SEP 21 ... Human Immunodeficiency Virus, Lamivudine, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Retrovirus, ...
Subject: HIV/AIDS
View Free
Daily News
Article
Researchers from Catholic University report recent findings in HIV/AIDS
2009 NOV 16 ... Virus, Lamivudine, Nucleoside Analog, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Protease Inhibitor, Protease Inhibitors, Proteins, Proteomics, ...
Subject: HIV/AIDS
Price: $3.00
*
Scientists at National Institutes of Health report research in antiretrovirals
2009 NOV 16 ... Chemotherapy, Drug Therapy, Drugs, HIV, Human Immunodeficiency Virus, Immunology, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Pharmacokinetics, Sexually Transmitted Disease, Tenofovir, Therapy, ...
Subject: Antiretrovirals
Price: $3.00
*
Studies from B.P. Kearney and colleagues reveal new findings on pharmacokinetics
2009 SEP 14 ... Contraception, Drug Development, Drugs, Estradiol, Ethinyl Estradiol, Norgestimate, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Oral Contraceptive, Pharmaceuticals, Pharmacokinetics, Pharmacotherapy, Tenofovir ...
Subject: Pharmacokinetics
Price: $3.00
*
Studies from Chelsea and Westminster Hospital NHS Trust yield new information about HIV/AIDS
2009 SEP 14 ... Reverse Transcriptase Inhibitor, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Sexually Transmitted Disease, Tenofovir Disoproxil Fumarate, Therapy, ...
Subject: HIV/AIDS
Price: $3.00
*
Studies from L. Durandgasselin and colleagues reveal new findings on pharmaceuticals
2009 OCT 5 ... Molecular Research, Molecular Therapies, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Pharmacokinetics, Physiology, Prodrug, Tenofovir, Treatment, Viral ...
Subject: Pharmaceuticals
Price: $3.00
*
Studies from V. Solinova et al add new findings in the area of HIV/AIDS
2009 SEP 28 ... Antiviral, Dietary Supplement, Human Immunodeficiency Virus, Immunology, Micronutrient, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Tenofovir, Treatment, Viral Inhibition, Viral Therapy, Virology. This ...
Subject: HIV/AIDS
Price: $3.00
*
Study results from N.A. Margot and colleagues in the area of HIV/AIDS published
2009 NOV 9 ... Reverse Transcriptase Inhibitor, Nucleoside Reverse Transcriptase Inhibitor, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Pharmaceuticals, Proteins, Proteomics, Sexually Transmitted Disease, Tenofovir ...
Subject: HIV/AIDS
Price: $3.00
*
Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
2009 SEP 28 ... Biotechnology, Darunavir, Drugs, Etravirine, HIV, Human Immunodeficiency Virus, Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAntiretroviral, Protease Inhibitor, Raltegravir, Tenofovir, Therapy, Treatment, Virology, Darunavir, ...
Subject: HIV/AIDS
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login